Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Metadeq Announces Breakthrough Non-Invasive Blood Test that Solves NASH Diagnosis Problem
Metadeq Inc., a global NASH and metabolic diseases diagnostics company, today announced a breakthrough non-invasive […]
Medtronic Expands Health Equity Assistance Program for Colon Cancer Screening With Support From Amazon Web Services; Completes First Installation of Donated GI Genius™ Intelligent Endoscopy Modules
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, and the American Society for Gastrointestinal Endoscopy (ASGE) today […]
NICE Recommends Novartis’ Piqray ® (Alpelisib) as a Targeted Treatment for Thousands of Advanced Breast Cancer Patients
Today Novartis Pharmaceuticals UK announces that the National Institute for Health and Care Excellence (NICE) […]
Breakthrough Treatment to Boost Life Chances for Hundreds of People With Respiratory Cancer
The first new mesothelioma treatment to be approved in nearly 15 years will be made […]
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for […]
Adipopharma’s First-in-class Candidate - PATAS - Shows Improvement in Whole-body Insulin Resistance and Associated Comorbidities in Vivo
AdipoPharma, formerly ALMS Therapeutics SAS, a biopharmaceutical company focused on innovative peptide-based approaches to treating […]
Thousands Of Patients To Benefit As NHS Marks 100th Fast-Tracked Cancer Drug
Thousands of people a year with advanced breast cancer will benefit from a life-extending drug […]
Moderna's Omicron-containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared to Currently Authorized Booster
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
Moderna Announces First Participant Dosed in a Phase 1 Trial of Its Nipah Virus mRNA Vaccine, mRNA-1215
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more